Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001415889-24-023619 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-18 | 2024-09-16 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | +7,197 | 47.1K | +18% | $0 |
| D | 2024-09-18 | 2024-09-16 | WGS | Feeley Kevin | CFO | S - Sale+OE | $37.59 | -2,635 | 44.5K | -6% | -$99.0K |
| D | 2024-09-18 | 2024-09-16 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | -7,197 | 72.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-09-16 | M | A | 7,197 | $0.00 | 47,107 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2024-09-16 | S | D | 2,635 | $37.59 | 44,472 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-09-16 | M | D | 7,197 | $0.00 | 71,969 | D | — · — to — | 7,197 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |